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With about 2–11% of pregnancy co‑existing with fibroids, one in 10 women will have complications related to myoma in pregnancy. 
The procedure of cesarean myomectomy has been much discouraged and the need to perform inevitable myomectomy during 
the cesarean section (CS) when fibroids obstruct wound closure has been presented. A case of a primigravida with huge uterine 
fibroids displacing the fetus into a persistent oblique lie and causing maternal discomfort is presented. A planned cesarean 
myomectomy was performed. Hemorrhage was controlled with tourniquet using Foley catheter, misoprostol, and high dose 
oxytocin infusion. The mother and baby had a satisfactory outcome. Elective cesarean myomectomy is safe but should only 
be done by an experienced surgeon and in centers equipped with facilities for comprehensive emergency obstetric care.
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Introduction
Fibroids coexist with pregnancy in about 2–11% of pregnant 
women,[1,2] and maybe an indication for or contributor to 
cesarean delivery.[2,3] A frequent request by patients with 
previously diagnosed myoma is usually its simultaneous 
removal during the time of the cesarean section (CS). 
Although the first case of cesarean myomectomy was reported 
about a century ago by Bonney,[4] it has been a controversial 
procedure because of the increased risk of associated 
morbidities such as hemorrhage with increased risk of blood 
transfusion, hysterectomy, postoperative febrile morbidities, 
and increased analgesic requirement. Evidences are however 
accruing of its safety in well-selected patients.[5,6] Most of 
cesarean myomectomies done are for fibroid nodules that are 
small in size (1–13 cm), pedunculated, subserosal, or those 
inevitably located in the line of uterine incision to deliver 
the baby.[3,7,8] We present the case of a woman with five giant 
intramural fibroids (largest measuring 36 × 26 × 22 cm) who 
underwent a planned cesarean myomectomy.
Case Report
A 35-year-old unbooked primigravida was seen at the obstetric 
unit at an estimated gestational age (EGA) of 34 weeks with 
complaints of huge coexisting uterine fibroids with her 
pregnancy causing her discomfort. She had been diagnosed 
with uterine fibroid about 2 years earlier following evaluation 
for infertility and was arranging for its removal when she 
spontaneously conceived this pregnancy and had cervical 
cerclage done at EGA of 17 weeks at a private hospital where 
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she was initially managed. The fibroid masses were noticed 
to be increasing in size as the pregnancy progressed with 
associated increasing discomfort but there was no abdominal 
pain. On examination, she was not pale, not dehydrated but 
had bilateral pitting pedal edema up to the lower third of her 
legs. Her vital signs were within normal limits. The abdomen 
was grossly distended, irregular and shiny. She was unable to 
lie down in both supine and left lateral positions, the uterine 
limits could not be delineated and the other intraabdominal 
organs could not be assessed. The largest fibroid was huge 
measuring about 36 × 28 cm continuous with the uterus, not 
mobile nor tender. In addition, there were 4 smaller fibroids 
left superolateral border of the uterus. The fetus was observed 
to be in an oblique lie in the right hypochondrium oriented 
along the plane of the subcostal angle with fetal heart rate 
(FHR) of 136 bpm. She was admitted and nursed propped up 
in bed. Results of full blood count, renal and liver function 
tests, clotting profile were all within normal limits. Ultrasound 
scan measured the fibroid mass to be 18.56 cm × 13.49 cm 
pushing the fetus to the right of the maternal abdomen. She was 
managed expectantly, thromboembolic prophylaxis measures 
put in place, had four units of blood crossmatched for her, and 
was counseled for elective cesarean myomectomy at term.
She had cesarean myomectomy done under general anesthesia 
with endotracheal intubation at EGA 37 weeks. A midline incision 
with supraumbilical extension was made and about 300 mls of 
straw-colored ascitic fluid was drained from the peritoneal cavity. 
A live male baby weighing 3.2 Kg was delivered together with 
the placenta via a lower segment uterine incision. Intravenous 
oxytocin 40 iu in 500 mls of normal saline was infused and 
tourniquet using a size 24Fr Foley catheter was then applied 
to occlude both uterine and ovarian arteries as shown in 
Figure 1. A fibroid nodule with cystic degeneration measuring 
32 × 26 cm and weighing 5.5 kg was enucleated from the 
anterior myometrium and four fibroid others nodules ranging 
from 5–12 cm in diameter were removed. The tourniquet was 
removed after the dead spaces and hysterotomy sites were closed 
up [Figure 2] and uterotonics were administered. The procedure 
lasted about 3 hours with an estimated blood loss of 1L, and 
she was transfused with 3 units of blood and one fresh frozen 
plasma both intra and postoperatively. She also had postoperative 
analgesia with pentazocine interspersed with diclofenac. For 
antibiotic coverage, she had cefuroxime and metronidazole for 
1 week. She had an unremarkable postoperative period and was 
discharged home on the 6th postoperative day.
Discussion
Myomectomy during CS remains a controversial topic. 
However, recent studies have shown no difference in the 
mean hemoglobin change, the incidence of postoperative 
fever, and the length of hospital stay between patients 
with fibromyomas who underwent a myomectomy during 
a CS delivery and those with or without fibromyomas that 
underwent CS deliveries.[5,9,10] A huge fibroid has been defined 
as a fibroid with a diameter of 5 cm and has been implicated 
as a risk factor for complications.[11-13] Cesarean myomectomy 
is less frequently performed in cases of intramural and 
multiple myomas. However, more often performed in patients 
affected by pedunculated and subserosal myoma[14] As large 
as a 30 cm × 25 cm × 25 cm subserosal fibroid weighing 
5290 g has been removed with an estimated blood loss of 1L 
and the procedure lasting 4 hours.[15] Our patient had a huge 
intramural fibroid measuring 36 cm × 26 cm × 22 cm and 
the estimated blood loss was comparable but with shorter 
duration of surgery. The trans-endometrial approach as 
opposed to the trans-serosal approach has been proposed 
and is said to be safe, feasible, and with less intraoperative 
blood loss, and has the potential to diminish the risk of 
abdominal adhesion formation.[16] However, the size of this 
fibroid precluded the use of this approach.
Figure 1: Applying tourniquet after delivery of the baby Figure 2: The uterus after removing the fibroids and closure of the cavities
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Several surgical techniques have been developed to reduce 
hemorrhage associated with cesarean myomectomy, 
including bilateral ligation of ascending arteries, application 
of a tourniquet, selective uterine devascularization, and 
the administration of intravenous oxytocin. Lee and Cho 
described the use of purse-string sutures around the myoma 
before enucleation to reduce blood loss.[17] Increasingly, more 
of these procedures are done under spinal or combined 
spinal- epidural anesthesia mainly due to the small sizes of 
the fibroid. However, because of the huge size of this fibroid, 
general anesthesia was used. Cesarean myomectomy increases 
the risk of perioperative blood transfusion and the patient had 
three units of blood transfused which is expected for the size 
of the fibroid.[14,15] However, there was no febrile morbidity.
It is noteworthy to point out that at our center (Obafemi 
Awolowo University Teaching Hospitals Complex, Ile-ife, 
Nigeria), in 2016, a cross-sectional study was carried out on 
the correlates between uterine fibroids and estrogen receptor 
α (ERα) and progesterone receptor (PR). The tumor diameter 
correlated negatively with the immunoscores of both receptors 
irrespective of age, parity, and body mass index but this was 
only significant for PR (β = -0.44, P ≤	0.001).	Downregulation	
of PR on uterine fibroids occurred at a diameter of 11 cm. It 
was concluded that uterine fibroids seemed to depend on a 
steroid but only during the early tumor development. This 
could have implications for the selection of patients for medical 
management, especially with steroid receptor modulators.[18] 
It was summarized that fibroids that have grown to huge 
proportions such as this case may not be amenable to medical 
management with steroid receptor modulators. Consequently, 
surgical intervention might be the only feasible option.
This case is unique because of its giant nature, intramural 
location, a planned procedure, and successful removal with 
uneventful postoperative recovery.
Conclusions
The possibility of safely performing myomectomy during 
CS is appealing in the low-resource settings of sub-Saharan 
Africa where fibroids are common and it saves costs by 
obviating subsequent interval myomectomy. Elective 
cesarean myomectomy is safe but should only be done by an 
experienced surgeon and in centers equipped with facilities 
for comprehensive emergency obstetric care as in this case.
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